Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Adolescents With ADHD
Clinical trial NCT03247517 · COMPLETED
Trial details
- NCT number
- NCT03247517
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-02
- Primary completion
- 2018-10-17
- Enrollment
- 310
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.